Die richtige Einstellung : Microdosing und die Medikamentierung des Alltags
Stefan Höhne
KWI-Blog 2023 DOI: 10.37189/kwi-blog/20230724-0830 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Microdosing |
| Keywords | Die integrated circuit Nanotechnology |
| Citations | 2 |
| Key findings | Reviews evidence suggesting psilocybin-assisted therapy may reduce depressive symptoms, with effects possibly lasting weeks to months, but calls for more research on dosing and long-term outcomes. |
Abstract
2023-07-24
Comparable studies
Other narrative reviews on microdosing, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Big physics, small doses: the use of AMS and PET in human microdosing of development drugs | 2003 | Review | |
| Phase 0/microdosing approaches: time for mainstream application in drug development? | 2020 | Review | |
| Microdosing and drug development: past, present and future | 2013 | Review | |
| Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development | 2016 | Review | |
| Expectancy Effects in Psychedelic Trials. | 2024 | Review |
Citations in the library
Cites 4
- Self-blinding citizen science to explore psychedelic microdosing. Elife March 2, 2021
- Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study. Addiction Biology February 1, 2022
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study Journal of Psychopharmacology December 17, 2021
- Author response: Self-blinding citizen science to explore psychedelic microdosing December 11, 2020